this review describes the rationale for the use of the thymidine analogs 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine in hepatic arterial infusions and indicates how combination therapy adding radiotherapy , specifically with hepatic arterially administered yttrium-90 microspheres , might generate a new , more efficient and effective therapeutic approach .
C0011535
deoxyuridine
C0020811
5-iodo-2